Close

AcelRx Pharma (ACRX) Names Vincent J. Angotti as CEO

February 16, 2017 4:46 PM EST Send to a Friend
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login